Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8510
-0.0656 (-7.16%)
At close: Aug 20, 2026, 4:00 PM EDT
0.8500
-0.0010 (-0.12%)
After-hours: Aug 20, 2026, 6:06 PM EDT
RANI Market Cap
RANI has a market cap or net worth of $118.63 million as of August 20, 2026. Its market cap has increased by 347.20% in one year.
Market Cap
118.63M
Enterprise Value
68.78M
1-Year Change
347.20%
Ranking
Category
Stock Price
$0.85
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $206.13M to $118.63M, a decrease of -42.45%. That is a compound annual growth rate of -10.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 105.80M | -19.66% |
| Dec 31, 2025 | 131.69M | 188.57% |
| Dec 31, 2024 | 45.64M | -46.89% |
| Dec 29, 2023 | 85.92M | -41.09% |
| Dec 30, 2022 | 145.85M | -54.75% |
| Dec 31, 2021 | 322.29M | 56.36% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 116.42M |
| Cue Biopharma | 116.10M |
| Yarrow Bioscience | 115.92M |
| enGene Therapeutics | 113.88M |
| Indaptus Therapeutics | 113.24M |
| Seer, Inc. | 112.41M |
| Nautilus Biotechnology | 112.05M |
| Coya Therapeutics | 109.55M |